BBV-15080-58849
2 vaccinations
3 coded responses
18 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 551 / MN
- Registered
- 2021-02-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-09
Registered in v-safe
-
2021-02-09
Dose 1 — Pfizer-BioNTech
- 2021-02-10
- 2021-02-11
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-23
-
2021-03-02
Dose 2 — Pfizer-BioNTech
- 2021-03-04
- 2021-03-06
-
2021-03-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-09
- 2021-03-18
- 2021-03-23
- 2021-03-30
-
2021-04-06
Survey response — day 35, dose 2MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: HeadachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-13
-
2021-06-01
Survey response — 3 months, dose 2MedDRA: Gestational diabetes — Feeling: Good · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Gestational diabetesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-01
Report sent to call center — 3 months, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-10
-
2021-08-31
Survey response — 6 months, dose 2MedDRA: Caesarean section, Complication of pregnancy, Gestational diabetes, Hypertension, Uterine rupture — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Emergency Caesarean section at 27 weeks due to uterine abruption - pregnancy complicated by hypertension and gestational diabetesMedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-09 | Pfizer-BioNTech | |
| 2 | 2021-03-02 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — day 35, dose 2
Symptoms: Headaches
Release 8 — 3 months, dose 2
Symptoms: Gestational diabetes
Release 9 — 6 months, dose 2
Symptoms: Emergency Caesarean section at 27 weeks due to uterine abruption - pregnancy complicated by hypertension and gestational diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Caesarean section | ✓ | · | ✓ |
| SD | Complication of pregnancy | ✓ | · | ✓ |
| SD | Gestational diabetes | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypertension | ✓ | · | ✓ |
| SD | Uterine rupture | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release